PL341604A1 - Local application ophthalmic preparations containing immunossuppressive agents - Google Patents

Local application ophthalmic preparations containing immunossuppressive agents

Info

Publication number
PL341604A1
PL341604A1 PL98341604A PL34160498A PL341604A1 PL 341604 A1 PL341604 A1 PL 341604A1 PL 98341604 A PL98341604 A PL 98341604A PL 34160498 A PL34160498 A PL 34160498A PL 341604 A1 PL341604 A1 PL 341604A1
Authority
PL
Poland
Prior art keywords
immunossuppressive
agents
local application
preparations containing
ophthalmic preparations
Prior art date
Application number
PL98341604A
Inventor
Milan Stuchlik
Alexandr Jegorov
Vladimir Matha
Josef Stuchlik
Original Assignee
Galena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galena filed Critical Galena
Publication of PL341604A1 publication Critical patent/PL341604A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL98341604A 1997-12-30 1998-12-17 Local application ophthalmic preparations containing immunossuppressive agents PL341604A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ19974237A CZ287497B6 (en) 1997-12-30 1997-12-30 Topic eye preparations containing immunosuppressive substances
PCT/CZ1998/000054 WO1999034830A1 (en) 1997-12-30 1998-12-17 Topical ophthalmic preparations containing immunosuppressive agents

Publications (1)

Publication Number Publication Date
PL341604A1 true PL341604A1 (en) 2001-04-23

Family

ID=5467853

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98341604A PL341604A1 (en) 1997-12-30 1998-12-17 Local application ophthalmic preparations containing immunossuppressive agents

Country Status (12)

Country Link
EP (1) EP1058560A1 (en)
JP (1) JP2002500200A (en)
AU (1) AU1481399A (en)
BG (1) BG104558A (en)
CA (1) CA2317010A1 (en)
CZ (1) CZ287497B6 (en)
HR (1) HRP20000258A2 (en)
HU (1) HUP0004173A2 (en)
NO (1) NO20003344D0 (en)
PL (1) PL341604A1 (en)
SK (1) SK284246B6 (en)
WO (1) WO1999034830A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ513111A (en) * 1998-12-24 2003-10-31 R Tech Ueno Ltd Agent for treating visual cell function disorder
US6864232B1 (en) 1998-12-24 2005-03-08 Sucampo Ag Agent for treating visual cell function disorder
TWI324925B (en) * 2001-08-23 2010-05-21 Novartis Ag Ophthalmic composition
PT1539157E (en) 2002-09-18 2013-10-04 Univ Pennsylvania Rapamycin for use in inhibiting or preventing choroidal neovascularization
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US7083802B2 (en) * 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
ES2564194T3 (en) 2005-02-09 2016-03-18 Santen Pharmaceutical Co., Ltd. Liquid formulations for the treatment of diseases or ailments
PL1904056T3 (en) 2005-07-18 2009-09-30 Minu Llc Use of a macrolide to restore corneal sensation
BRPI0707612B8 (en) 2006-02-09 2021-05-25 Macusight Inc sealed vessel and liquid formulations contained therein
US8222271B2 (en) 2006-03-23 2012-07-17 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
AU2014209141B2 (en) 2013-01-24 2018-05-10 Palvella Therapeutics, Inc. Compositions for transdermal delivery of mTOR inhibitors
AU2013384818A1 (en) * 2013-03-27 2015-11-12 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
US11622929B2 (en) 2016-03-08 2023-04-11 Living Proof, Inc. Long lasting cosmetic compositions
AU2018205253B2 (en) 2017-01-06 2022-01-13 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use
WO2019055440A1 (en) 2017-09-13 2019-03-21 Living Proof, Inc. Long lasting cosmetic compositions
CA3074845A1 (en) 2017-09-13 2019-03-21 Living Proof, Inc. Color protectant compositions
US11000513B2 (en) 2018-07-02 2021-05-11 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051260A (en) * 1987-07-16 1991-09-24 The Regents Of The University Of California Method and composition for enhancing the cutaneous penetration of pharmacologically active agents
US4971800A (en) * 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US5045317A (en) * 1987-07-16 1991-09-03 The Regents Of The University Of California Enhancing the cutaneous penetration of pharmacologically active agents

Also Published As

Publication number Publication date
AU1481399A (en) 1999-07-26
SK171798A3 (en) 1999-10-08
JP2002500200A (en) 2002-01-08
NO20003344L (en) 2000-06-27
HUP0004173A2 (en) 2001-08-28
CZ423797A3 (en) 1999-07-14
WO1999034830A1 (en) 1999-07-15
HRP20000258A2 (en) 2001-04-30
CA2317010A1 (en) 1999-07-15
SK284246B6 (en) 2004-12-01
BG104558A (en) 2001-02-28
NO20003344D0 (en) 2000-06-27
EP1058560A1 (en) 2000-12-13
CZ287497B6 (en) 2000-12-13

Similar Documents

Publication Publication Date Title
GB9420657D0 (en) Contrast agents
GB9708484D0 (en) Therapeutic agents
GB9708945D0 (en) Therapeutic agents
SG76535A1 (en) Pharmaceutical agents
PL341604A1 (en) Local application ophthalmic preparations containing immunossuppressive agents
GB9704948D0 (en) Therapeutic agents
GB9702524D0 (en) Therapeutic agents
GB9711753D0 (en) Therapeutic agents
GB9713707D0 (en) Therapeutic agents
EP0920869A4 (en) Stable aspirin-containing preparations for external use
GB9501560D0 (en) Contrast agents
GB9715977D0 (en) Therapeutic agents
GB9711114D0 (en) Therapeutic agents
ZA951232B (en) Contrast agents
PL340555A1 (en) Preparations containing dissolved paroxetin
GB9702392D0 (en) Therapeutic agents
PL338382A1 (en) Dyeing agents
PL336805A1 (en) Pharmaceutic agents containing thysoxanide and intazoxanide
GB9718712D0 (en) Theraputic Agents
GB9700555D0 (en) Therapeutic agents
AU1171099A (en) Therapeutic agents
GB9716463D0 (en) Therapeutic agents
EP1004309A4 (en) Israpafant-containing water-base preparations
HUP0003038A3 (en) Low dosed 15-desoxyspergualine preparations
IL136525A0 (en) Agents